NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO) Valuation Check After New Orbitrap Mass Spectrometers Launch
Thermo Fisher Scientific (TMO) is back in focus after unveiling its Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at the ASMS 2026 conference, refocusing attention on its high-end analytical instruments portfolio.
See our latest analysis for Thermo Fisher Scientific.
The stock has come under pressure in recent months, with the share price down 20.2% year to date and weaker over the past quarter. However, the 1 year total shareholder return of 18.07% remains positive,...